Skip to main content
STLN logo

STLN · Starling Oncology, Inc. · Documents

Track STLN — free
$3.26 +0.06 (+1.88%) Play latest call Q2 2026 earnings call transcript
Market Cap
$326.37M
Shares
101.99M
Volume · Nov 18 4.68M Avg daily vol (3M) 2.45M

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

2025
Mar 26
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $393.41M ▲ 21.3% Net loss $64.66M Diluted EPS -$0.71
2024
Mar 28
Annual report 10-K FY2023, ended Dec 31
Annual report for FY2023
Revenue $324.24M ▲ 28.4% Net loss $83.07M Diluted EPS -$0.92
2023
Showing 51–100 of 170 documents
Key facts CIK 1799191 CUSIP 68236X100 13F (30d) 140 filings 127 filers Visit website Investor relations